The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation-Reference-Cited by-同舟云学术

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Published:2018-03-19 Issue:16 Volume:39 Page:1330-1393
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Steffel Jan¹,Verhamme Peter²,Potpara Tatjana S³,Albaladejo Pierre⁴,Antz Matthias⁵,Desteghe Lien⁶,Haeusler Karl Georg⁷,Oldgren Jonas⁸,Reinecke Holger⁹,Roldan-Schilling Vanessa¹⁰,Rowell Nigel¹¹,Sinnaeve Peter²,Collins Ronan¹²,Camm A John¹³,Heidbüchel Hein⁶¹⁴,Lip Gregory Y H,Weitz Jeffrey,Fauchier Laurent,Lane Deirdre,Boriani Giuseppe,Goette Andreas,Keegan Roberto,MacFadyen Robert,Chiang Chern-En,Joung Boyoung,Shimizu Wataru,

Affiliation:

1. Department of Cardiology, University Heart Center Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland

2. Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium

3. School of Medicine, Belgrade University, Belgrade, Serbia

4. Grenoble-Alps University Hospital, Grenoble, France

5. City Hospital Braunschweig, Braunschweig, Germany

6. Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium

7. Center for Stroke Research Berlin and Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin, Germany

8. Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden

9. Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany

10. University of Murcia, Murcia, Spain

11. Middlesbrough, UK

12. Age-Related Health Care & Stroke-Service, Tallaght Hospital, Dublin Ireland

13. Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St George’s University, London, UK, and Imperial College

14. Antwerp University and University Hospital, Antwerp, Belgium

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/39/16/1330/24690548/ehy136.pdf

Reference476 articles.

1. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation;Heidbuchel;Europace,2013

2. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation;Heidbuchel;Europace,2015

3. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

4. Recommendation on the Nomenclature for Oral Anticoagulants: communication from the SSC of the ISTH;Barnes;J Thromb Haemost,2015

5. 2017 ESC/EACTS Guidelines for the management of valvular heart disease;Baumgartner;Eur Heart J,2017

Cited by 1636 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

2. Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis;Heart & Lung;2024-09

3. Impact of Direct Oral Anticoagulant Levels on Functional Independence Following Endovascular Thrombectomy in Patients With Atrial Fibrillation;Stroke: Vascular and Interventional Neurology;2024-09

4. Continuation versus Interruption of Oral Anticoagulation during TAVI;New England Journal of Medicine;2024-08-31

5. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30